作者: J. R. Rodrigue , S. Feng , A. C. Johansson , A. K. Glazier , P. L. Abt
DOI: 10.1111/AJT.13482
关键词: Total quality management 、 Context (language use) 、 Institutional review board 、 Risk assessment 、 Organ procurement organization 、 Intervention (counseling) 、 Organ transplantation 、 Informed consent 、 Medicine 、 Family medicine
摘要: Innovative deceased donor intervention strategies have the potential to increase number and quality of transplantable organs. Yet there is confusion over regulatory legal requirements, as well ethical considerations. We surveyed transplant surgeons (n = 294), organ procurement organization (OPO) professionals (n = 83), institutional review board (IRB) members (n = 317) found wide variations in their perceptions about research classification, risk assessment for donors recipients, oversight informed consent context research. For instance, when presented with different scenarios, IRB were more likely than OPO feel that study necessary by IRBs at investigator, donor, center hospitals. Survey findings underscore need clarify ethical, legal, requirements application accelerate pace scientific discovery facilitate transplants.